Ornithine aminotransferase inhibition with GABA analogues for treatment of hepatocellular carcinoma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9603820
APP PUB NO 20160128958A1
SERIAL NO

14936153

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Therapeutic methods relating to the use of GABA-AT inhibitor compounds for the treatment of hepatocellular carcinoma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTDJERUSALEM BIOPARK HADASSAH EIN KEREM MEDICAL CENTER JERUSALEM 9112001

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ilan, Yaron Kfar Tavor, IL 103 375
Silverman, Richard B Winnetka, US 124 993

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00